Advertisement

Topics

Long-Term Data Support Stereotactic Body Radiotherapy for Centrally Located NSCLC

20:00 EDT 8 May 2019 | Cancer Networks

The findings further validate the initial 2015 findings that a five-fraction SBRT schedule is appropriate for patients with centrally located NSCLC.

Original Article: Long-Term Data Support Stereotactic Body Radiotherapy for Centrally Located NSCLC

NEXT ARTICLE

More From BioPortfolio on "Long-Term Data Support Stereotactic Body Radiotherapy for Centrally Located NSCLC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...